Sept. 08, 2025 — A new clinical case study, presented by Qure.ai and Hacettepe University, Turkey, at the IASLC World Conference on Lung Cancer 2025 in Barcelona, shows that Artificial Intelligence (AI) can detect potentially malignant pulmonary nodules on routine chest X-rays (CXRs), even when the imaging was ordered for unrelated, non-respiratory conditions.

Sept. 3, 2025 — According to ARRS’ American Journal of Roentgenology (AJR), a commercial artificial intelligence (AI) system achieved high negative predictive value (NPV) but also demonstrated higher recall rates than radiologists when applied to large digital mammography (DM) and digital breast tomosynthesis (DBT) screening cohorts.

Sept. 4, 2025 — Sentec recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent and adult patients — making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. 

Sept. 4, 2025 — Ultrasound AI recently announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,369,883, "Artificial Intelligence System for Determining Clinical Values through Medical Imaging." The patent protects the company's proprietary system for determining current or future clinical or laboratory values directly from non-invasive medical images such as ultrasound.

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced that the first patient has been treated in its U.S. multi-center pancreatic cancer pilot study, known as IMPACT (Intratumoral Pancreatic Alpha Combination Trial), evaluating the safety, feasibility and efficacy of Alpha DaRT in combination with chemotherapy for patients with newly diagnosed unresectable locally advanced or metastatic pancreatic adenocarcinoma.

Sept. 4, 2025 — University Hospitals health system in Cleveland recently became the first healthcare institution in the United States to install the Naeotom Alpha.Pro from Siemens Healthineers, the world’s second dual-source scanner with photon-counting computed tomography (PCCT) technology.

Sept. 4, 2025 — 4DMedical, a global medical technology company, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ, the world's the company's non-contrast, ventilation–perfusion (V/Q) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.

Using AI to Detect Tiny Brain Metastases

Brain metastases are 10 times more common than primary brain tumors, occurring in 10 to 20% of adult patients with cancer.1 The current limit of detection clinically is 2 to 5 mm in diameter, though metastases are more typically detected between 5 mm and 1 cm.2 Yet in their earliest stages, metastases can be 3 mm or smaller, making them challenging to identify on an MRI.

Sept. 2, 2025 — As American hospitals continue to grapple with an increasing shortage of specialized medical imaging technologists, a new partnership is turning a little-known hardware device into a critical lifesaving tool. Currently, the U.S. is facing a radiographer staffing shortfall of 15.6%, with experts continuing to sound the alarm.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now